Profile | GDS5420 / 218214_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 623.49 | 71 |
GSM1296119 | B_lesional_pre-dose | 328.03 | 61 |
GSM1296076 | C_lesional_pre-dose | 457.09 | 67 |
GSM1296092 | D_lesional_pre-dose | 784.12 | 75 |
GSM1296103 | E_lesional_pre-dose | 1069.3 | 80 |
GSM1296078 | F_lesional_pre-dose | 420.49 | 66 |
GSM1296107 | G_lesional_pre-dose | 379.62 | 63 |
GSM1296109 | H_lesional_pre-dose | 777.04 | 75 |
GSM1296080 | I_lesional_pre-dose | 771.84 | 75 |
GSM1296090 | J_lesional_pre-dose | 695.74 | 73 |
GSM1296074 | K_lesional_pre-dose | 497.41 | 69 |
GSM1296111 | L_lesional_pre-dose | 344.34 | 61 |
GSM1296099 | M_lesional_pre-dose | 758.41 | 74 |
GSM1296086 | O_lesional_pre-dose | 699.03 | 73 |
GSM1296117 | P_lesional_pre-dose | 360.7 | 62 |
GSM1296113 | Q_lesional_pre-dose | 387.92 | 63 |
GSM1296096 | R_lesional_pre-dose | 825.94 | 76 |
GSM1296105 | S_lesional_pre-dose | 509.73 | 68 |
GSM1296098 | T_lesional_pre-dose | 672.63 | 72 |
GSM1296101 | U_lesional_pre-dose | 800.79 | 75 |
GSM1296121 | V_lesional_pre-dose | 428.19 | 65 |
GSM1296088 | W_lesional_pre-dose | 754.23 | 74 |
GSM1296082 | X_lesional_pre-dose | 689.56 | 73 |
GSM1296115 | Y_lesional_pre-dose | 458.3 | 66 |
GSM1296084 | Z_lesional_pre-dose | 758.5 | 75 |
GSM1296072 | B_lesional_day8 | 368.52 | 62 |
GSM1296069 | L_lesional_day8 | 314.59 | 59 |
GSM1296071 | P_lesional_day8 | 358.36 | 61 |
GSM1296070 | Y_lesional_day8 | 376.71 | 62 |
GSM1296073 | V_lesional_day8 | 370.19 | 63 |
GSM1296034 | A_lesional_day15 | 623.21 | 71 |
GSM1296041 | G_lesional_day15 | 328.71 | 61 |
GSM1296035 | R_lesional_day15 | 845.35 | 76 |
GSM1296038 | U_lesional_day15 | 510.77 | 68 |
GSM1296047 | B_lesional_day15 | 398.87 | 63 |
GSM1296039 | E_lesional_day15 | 529.97 | 69 |
GSM1296042 | H_lesional_day15 | 307.9 | 59 |
GSM1296043 | L_lesional_day15 | 370.58 | 62 |
GSM1296037 | M_lesional_day15 | 814.88 | 76 |
GSM1296046 | P_lesional_day15 | 330.25 | 60 |
GSM1296044 | Q_lesional_day15 | 358.75 | 61 |
GSM1296045 | Y_lesional_day15 | 347.68 | 61 |
GSM1296025 | C_lesional_day15 | 485.01 | 67 |
GSM1296033 | D_lesional_day15 | 872.35 | 77 |
GSM1296027 | I_lesional_day15 | 637.53 | 72 |
GSM1296032 | J_lesional_day15 | 779.99 | 75 |
GSM1296024 | K_lesional_day15 | 418.66 | 65 |
GSM1296031 | W_lesional_day15 | 569.41 | 70 |
GSM1296028 | X_lesional_day15 | 580.58 | 70 |
GSM1296029 | Z_lesional_day15 | 702.88 | 73 |
GSM1296026 | F_lesional_day15 | 438.48 | 66 |
GSM1296030 | O_lesional_day15 | 953.82 | 78 |
GSM1296040 | S_lesional_day15 | 969.34 | 79 |
GSM1296036 | T_lesional_day15 | 579.32 | 70 |
GSM1296048 | V_lesional_day15 | 428.65 | 65 |
GSM1296059 | A_lesional_day43 | 1021.92 | 79 |
GSM1296066 | G_lesional_day43 | 381.08 | 63 |
GSM1296060 | R_lesional_day43 | 642.72 | 72 |
GSM1296063 | U_lesional_day43 | 405.38 | 64 |
GSM1296064 | E_lesional_day43 | 627.92 | 72 |
GSM1296067 | H_lesional_day43 | 366.4 | 61 |
GSM1296062 | M_lesional_day43 | 800.25 | 75 |
GSM1296068 | Q_lesional_day43 | 347.88 | 60 |
GSM1296050 | C_lesional_day43 | 376.71 | 63 |
GSM1296057 | D_lesional_day43 | 859.07 | 76 |
GSM1296052 | I_lesional_day43 | 631.68 | 72 |
GSM1296054 | J_lesional_day43 | 634.15 | 71 |
GSM1296049 | K_lesional_day43 | 380.95 | 63 |
GSM1296055 | W_lesional_day43 | 618.04 | 71 |
GSM1296053 | X_lesional_day43 | 692.34 | 73 |
GSM1296058 | Z_lesional_day43 | 1226.86 | 82 |
GSM1296051 | F_lesional_day43 | 440.81 | 66 |
GSM1296056 | O_lesional_day43 | 839.91 | 76 |
GSM1296065 | S_lesional_day43 | 447.4 | 66 |
GSM1296061 | T_lesional_day43 | 696.33 | 73 |
GSM1296095 | A_non-lesional_pre-dose | 475.62 | 67 |
GSM1296120 | B_non-lesional_pre-dose | 366.63 | 62 |
GSM1296077 | C_non-lesional_pre-dose | 466.3 | 67 |
GSM1296093 | D_non-lesional_pre-dose | 784.48 | 75 |
GSM1296104 | E_non-lesional_pre-dose | 630.67 | 72 |
GSM1296079 | F_non-lesional_pre-dose | 375.54 | 63 |
GSM1296108 | G_non-lesional_pre-dose | 424.58 | 65 |
GSM1296110 | H_non-lesional_pre-dose | 413.17 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 699.73 | 73 |
GSM1296091 | J_non-lesional_pre-dose | 983.84 | 79 |
GSM1296075 | K_non-lesional_pre-dose | 430.51 | 66 |
GSM1296112 | L_non-lesional_pre-dose | 443.31 | 65 |
GSM1296100 | M_non-lesional_pre-dose | 1020.12 | 80 |
GSM1296087 | O_non-lesional_pre-dose | 754.8 | 74 |
GSM1296118 | P_non-lesional_pre-dose | 390.9 | 63 |
GSM1296114 | Q_non-lesional_pre-dose | 370.49 | 62 |
GSM1296097 | R_non-lesional_pre-dose | 681.96 | 73 |
GSM1296106 | S_non-lesional_pre-dose | 524.17 | 68 |
GSM1296102 | U_non-lesional_pre-dose | 580.61 | 70 |
GSM1296122 | V_non-lesional_pre-dose | 277.26 | 57 |
GSM1296089 | W_non-lesional_pre-dose | 733.79 | 74 |
GSM1296083 | X_non-lesional_pre-dose | 595.45 | 70 |
GSM1296116 | Y_non-lesional_pre-dose | 380.63 | 62 |
GSM1296085 | Z_non-lesional_pre-dose | 823.89 | 76 |